Description

The bacterin is prepared from chemically inactivated strains of E. coli. A sterile adjuvant is used to enhance the immune response.

Approved Uses

Vaccination of healthy, pregnant sows and gilts for passive transfer of protective maternal antibodies to their pigs against neonatal colibacillosis caused by enterotoxigenic strains of Escherichia coli producing heat-labile toxin or having the K99, K88, 987P, or F41 adherence factors. The addition of F41 offers broader protection than previously available. The bacterin is prepared from chemically inactivated strains of Escherichia coli. A sterile adjuvant is used to enhance the immune response.

Key Features